Загрузка...
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Liraglutide is a glucagon-like peptide-1 (GLP-1) analog marketed for the treatment of type 2 diabetes. Besides lowering blood glucose, liraglutide also reduces body weight. It is not fully understood how liraglutide induces weight loss or to what degree liraglutide acts directly in the brain. Here,...
Сохранить в:
Главные авторы: | , , , , , , , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
American Society for Clinical Investigation
2014
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4215190/ https://ncbi.nlm.nih.gov/pubmed/25202980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI75276 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|